Quest Diagnostics Cash Flow Statement
NYSE: DGXHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:01 PM ET · Delayed 15 min
Quest Diagnostics free cash flow
In fiscal 2025, Quest Diagnostics generated $1.89 billion of operating cash flow and spent $527.0 million on capital expenditures. That left free cash flow of $1.36 billion, a free-cash-flow margin of 12.3% of revenue. Free cash flow was up 49.5% from the prior year's $909.0 million.
Quest Diagnostics returned $803.0 million to shareholders: $353.0 million in dividends and $450.0 million in share repurchases, equal to 59% of free cash flow. Free cash flow covered dividend payments 3.8 times.
Summary generated from market data by MetaCap's automated system. Methodology
Quest Diagnostics cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.05B | 921.00M | 908.00M | 1.01B | 2.08B | 1.50B | 906.00M | 788.00M | 824.00M | 696.00M |
| Net Income growth (YoY) | +13.57% | +1.43% | -10.54% | -51.20% | +38.76% | +65.45% | +14.97% | -4.37% | +18.39% | -7.57% |
| Depreciation & Amortization | 570.00M | 493.00M | 439.00M | 437.00M | 408.00M | 361.00M | 329.00M | 309.00M | 270.00M | 249.00M |
| Stock-Based Compensation | 88.00M | 88.00M | 77.00M | 77.00M | 79.00M | 97.00M | 56.00M | 61.00M | 79.00M | 69.00M |
| Change in Working Capital | 23.00M | -138.00M | -70.00M | 97.00M | 116.00M | -3.00M | 10.00M | -84.00M | 1.00M | 14.00M |
| Operating Cash Flow | 1.89B | 1.33B | 1.27B | 1.72B | 2.23B | 2.00B | 1.24B | 1.20B | 1.18B | 1.12B |
| Capital Expenditures | -527.00M | -425.00M | -408.00M | -404.00M | -403.00M | -418.00M | -400.00M | -383.00M | -252.00M | -293.00M |
| Investing Cash Flow | -631.00M | -2.55B | -1.06B | -543.00M | 21.00M | -772.00M | -411.00M | -801.00M | -830.00M | -127.00M |
| Dividends Paid | -353.00M | -331.00M | -314.00M | -305.00M | -309.00M | -297.00M | -286.00M | -266.00M | -247.00M | -223.00M |
| Share Repurchases | -450.00M | -151.00M | -275.00M | -1.41B | -2.20B | -325.00M | -353.00M | -322.00M | -465.00M | -590.00M |
| Debt Issued | 410.00M | 1.85B | 2.59B | 0 | 0 | 749.00M | 2.28B | 2.09B | 205.00M | 1.87B |
| Debt Repaid | -1.01B | -303.00M | -1.84B | -2.00M | -2.00M | -1.55B | -1.45B | -1.97B | -182.00M | -1.73B |
| Financing Cash Flow | -1.39B | 1.08B | 160.00M | -1.73B | -2.54B | -1.27B | 225.00M | -401.00M | -592.00M | -738.00M |
| Net Change in Cash | -129.00M | -137.00M | 371.00M | -557.00M | -286.00M | -34.00M | 1.06B | -2.00M | -222.00M | 226.00M |
| Free Cash Flow | 1.36B | 909.00M | 864.00M | 1.31B | 1.83B | 1.59B | 843.00M | 817.00M | 923.00M | 823.00M |
This table shows 10 annual periods of Quest Diagnostics's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow DGX's reporting calendar. What is a cash flow statement?